EUCTR2008-002126-12-IT进行中（未招募）不适用
A randomized phase II study of progression free survival comparing gemcitabine (1250 mg/m2 infusion) versus carboplatin (AUC5 infusion) plus alimta (500 mg/m2 infusion) as first-line chemotherapy in elderly patients with locally advanced (stage IIIb) or metastatic (stage IV) non small cell lung cancer (NSCLC) - ND
ISTITUTO CLINICO HUMANITAS0 个研究点开始时间: 2008年7月9日最近更新:
相关药物
试验速览
- 阶段
- 不适用
- 状态
- 进行中（未招募）
- 发起方
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
- 性别
- All
入选标准
- •NSCLC, locally advanced (stage IIIB) or metastatic (stage IV) disease, not amenable to curative surgery or radiotherapy
- •Female or male patients aged 70 years and over
- •Measurable disease according to RECIST criteria, with at least one measurable lesion
- •No prior chemotherapy, biological or immunological therapy
- •Adeguate hepatic, renal and bone marrow function
- •ECOG Performance Status ≤ 2
- •Life expectancy of at least 12 weeks
- •Are the trial subjects under 18? no
- •Number of subjects for this age range:
- •F.1.2 Adults (18-64 years) no
- •F.1.2.1 Number of subjects for this age range
- •F.1.3 Elderly (>=65 years) yes
- •F.1.3.1 Number of subjects for this age range
排除标准
- •Newly diagnosed CNS metastases that have not been treated with surgery or radiation
- •Less than 4 weeks since completion of prior radiotherapy or persistence of any radiotherapy related toxicity
- •Any other experimental or anti-cancer therapy within 30 days before study drug administration
- •Concurrent treatment with any other experimental or anti-cancer therapy
研究者
相似试验
招募中
2 期
Everolimus Treatment in patients with Pancreatic CancerPancreatic Neuroendocrine TumoursCancer - PancreaticACTRN12612001252808Peter MacCallum Cancer Centre20
招募中
不适用
A Phase II Trial to Evaluate the Strategy of Integrating Local Ablative Therapy with First-Line Systemic Treatment for Unresectable Oligometastatic Colorectal Cancer (RESOLUTE)metastatic colorectal cancerCancer - Bowel - Back passage (rectum) or large bowel (colon)Cancer - Bowel - Small bowel (duodenum and ileum)ACTRN12621001198819Cancer Council Victoria50
招募中
2 期
Cisplatin and oral vinorelbine chemotherapy along with radiation for treatment of locally advanced lung cancerStage III Non Small Cell Lung CancerCancer - Lung - Non small cellACTRN12609000003279Royal Adelaide Hospital50
招募中
1 期
A clinical trial that examines whether the treatment with the medication olaparib in combination with the chemotherapy carboplatin is more effective than treatment with a standard chemotherapy (anthracycline/taxane-based) against a specific type of breast cancer (triple-negative) with a biologic characteristic (homologous recombination deficiency)Early invasive triple negative breast cancer with positive HRD status (acc. to Myriad mychoice© test)MedDRA version: 20.0Level: PTClassification code: 10075566Term: Triple negative breast cancer Class: 100000004864CTIS2024-512821-10-00Verein Zur Praevention Und Therapie Boesartiger Erkrankungen Austrian Breast And Colorectal Cancer Study Group90
进行中（未招募）
1 期
A clinical trial that examines whether the treatment with the medication olaparib in combination with the chemotherapy carboplatin is more effective than treatment with a standard chemotherapy (anthracycline/ taxane-based) against a specific type of breast cancer (triple-negative) with a biologic characteristic (homologous recombination deficiency)Early invasive triple negative breast cancer with positive HRD status (acc. to Myriad mychoice© test)MedDRA version: 20.0Level: PTClassification code 10075566Term: Triple negative breast cancerSystem Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)EUCTR2016-004384-39-ATAustrian Breast & Colorectal Cancer Study Group (ABCSG)90